Finally, we developed a prognostic stratification based on the expression levels of AMDHD1 and SMAD4, revealing that CCA patients with low levels of both AMDHD1 and SMAD4 exhibited the poorest OS. This evidence concerns the gene SMAD4 and cholangiocarcinoma.